Impact of comorbidities on patient-reported outcomes in psoriatic arthritis: the case of endometriosis

Biedroń G, Wil M, Nowakowski J et al (2024) Impact of comorbidities on patient-reported outcomes in psoriatic arthritis: a single centre cohort study. Rheumatol Int. https://doi.org/10.1007/s00296-024-05632-2 Lewinson RT, Vallerand IA, Lowerison MW, Parsons LM, Frolkis AD, Kaplan GG et al (2017) Depression is associated with an increased risk of psoriatic arthritis among patients with psoriasis: a population-based study. J Invest Dermatol 137(4):828–835 Zhao SS, Miller N, Harrison N, Duffield SJ, Dey M, Goodson NJ (2020) Systematic review of mental health comorbidities in psoriatic arthritis. Clin Rheumatol 39(1):217–225 Thomsen RS, Nilsen TIL, Haugeberg G, Gulati AM, Kavanaugh A, Hoff M (2021) Adiposity and physical activity as risk factors for developing psoriatic arthritis: longitudinal data from a population-based study in Norway. Arthritis Care Res 73(3):432–441 Coates LC, Bukhari M, Chan A et al (2024) Enhancing current guidance for psoriatic arthritis and its comorbidities: recommendations from an expert consensus panel. Rheumatol (Oxford) Mar 15:keae172 Elsawy NA, Helal AMH, Abd ElHamid HA, Abdel-Fattah YH (2021) Fibromyalgia in patients with psoriatic arthritis: impact on disease activity indices, fatigue and health-related quality of life. Int J Rheum Dis 24(2):189–196 Harris HR, Korkes KMN, Li T et al (2022) Endometriosis, psoriasis and psoriatic arthritis: a prospective cohort study. Am J Epidemiol 191:1050–1060 Symons LK, Miller JE, Kay VR, Marks RM, Liblik K, Koti M, Tayade C (2018) The immunopathophysiology of endometriosis. Trends Mol Med 24:748–762 Eisenberg VH, Zolti M, Soriano D (2012) Is there an association between autoimmunity and endometriosis? Autoimmun Rev 11:806–814 Zervou MI, Goulielmos GN (2024) Comment on: enhancing current guidance for psoriatic arthritis and its comorbidities: recommendations from an expert consensus panel. Rheumatol (Oxford) May 17:keae Kotlyar AM, Mamillapalli R, Flores VA et al (2021) Tofacitinib alters STAT3 signaling and leads to endometriosis lesion regression. Mol Hum Reprod 27:gaab016

Not applicable. Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors. Author information Authors and Affiliations Contributions M.I.Z. and G.N.G. designed the current study, searched the literature and drafted the manuscript. Corresponding author Ethics declarations Conflict of interest The authors have declared no conflicts of interest. Additional information Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Rights and permissions About this article Cite this article Zervou, M.I., Goulielmos, G.N. Impact of comorbidities on patient-reported outcomes in psoriatic arthritis: the case of endometriosis. Rheumatol Int 44, 1801–1802 (2024). https://doi.org/10.1007/s00296-024-05666-6 Received: Accepted: Published: Version of record: Issue date: DOI: https://doi.org/10.1007/s00296-024-05666-6